Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Synovics Pharmaceuticals Quick Ratio 2010-2009 | SYVC

Historical quick ratio values for Synovics Pharmaceuticals (SYVC) over the last 10 years.
  
Synovics Pharmaceuticals Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2009-07-31 $0.00B $0.02B 0.14
2009-04-30 $0.00B $0.02B 0.20
2009-01-31 $0.00B $0.01B 0.31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $0.000B
Synovics Pharmaceuticals, Inc. (formerly Bionutrics Inc.), through its subsidiaries, develops, manufactures, and commercializes generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products. The company's OTC product categories include analgesics, cough, cold, antihistamines, asthma relief, and laxatives. It also offers private label solid dosage Rx products, including Estratest, a product used by post-menopausal women. The company packages and distributes its private label, or store brand OTC products to chain drug stores, wholesalers, and distributors in the United States. It primarily has strategic alliance agreement with Maneesh Pharmaceuticals Pvt., Ltd. and Harcharan (Harry) Singh. Synovics Pharmaceuticals, Inc. operates as a subsidiary of Maneesh Pharmaceuticals Limited.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.617B 31.15
Chugai Pharmaceutical (CHGCY) Japan $51.784B 23.15
Takeda Pharmaceutical (TAK) Japan $41.491B 8.40
Merck (MKGAF) Germany $21.235B 20.04
Astellas Pharma (ALPMY) Japan $17.409B 27.49
Sandoz Group AG (SDZNY) Switzerland $15.266B 0.00
Shionogi (SGIOY) Japan $14.400B 12.52
Neurocrine Biosciences (NBIX) United States $13.702B 37.51
United Therapeutics (UTHR) United States $11.725B 12.50
Catalent (CTLT) United States $10.099B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.637B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.134B 7.84
Revolution Medicines (RVMD) United States $6.133B 0.00
Ionis Pharmaceuticals (IONS) United States $5.663B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Madrigal Pharmaceuticals (MDGL) United States $4.504B 0.00
Alpine Immune Sciences (ALPN) United States $4.455B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.780B 0.00
Summit Therapeutics (SMMT) United States $3.370B 0.00
Corcept Therapeutics (CORT) United States $2.866B 25.97
Arrowhead Pharmaceuticals (ARWR) United States $2.740B 0.00
Indivior (INDV) United States $2.464B 11.68
PTC Therapeutics (PTCT) United States $2.431B 0.00
Dyne Therapeutics (DYN) United States $2.326B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.225B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.060B 11.77
Catalyst Pharmaceuticals (CPRX) United States $1.916B 18.64
Evotec AG (EVO) Germany $1.896B 0.00
Ardelyx (ARDX) United States $1.866B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.823B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.804B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.586B 27.76
Avadel Pharmaceuticals (AVDL) Ireland $1.523B 0.00
Soleno Therapeutics (SLNO) United States $1.430B 0.00
Pacira BioSciences (PCRX) United States $1.414B 13.44
4D Molecular Therapeutics (FDMT) United States $1.322B 0.00
Xencor (XNCR) United States $1.316B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.162B 0.00
Enliven Therapeutics (ELVN) United States $1.151B 0.00
Cronos Group (CRON) Canada $1.119B 0.00
Collegium Pharmaceutical (COLL) United States $1.052B 6.29
Ironwood Pharmaceuticals (IRWD) United States $1.047B 16.32
Cassava Sciences (SAVA) United States $0.989B 0.00
USANA Health Sciences (USNA) United States $0.901B 14.73
Centessa Pharmaceuticals (CNTA) United Kingdom $0.890B 0.00
Ocular Therapeutix (OCUL) United States $0.874B 0.00
ARS Pharmaceuticals (SPRY) United States $0.861B 0.00
Relay Therapeutics (RLAY) United States $0.852B 0.00
Sage Therapeutics (SAGE) United States $0.732B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.716B 0.00
ProKidney (PROK) United States $0.706B 0.00
Savara (SVRA) United States $0.634B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.626B 0.00
Silence Therapeutics (SLN) United Kingdom $0.623B 0.00
Lyell Immunopharma (LYEL) United States $0.612B 0.00
Exscientia (EXAI) United Kingdom $0.594B 0.00
Siga Technologies (SIGA) United States $0.530B 6.77
OmniAb (OABI) United States $0.525B 0.00
Altimmune (ALT) United States $0.523B 0.00
Verve Therapeutics (VERV) United States $0.522B 0.00
KalVista Pharmaceuticals (KALV) United States $0.506B 0.00
Larimar Therapeutics (LRMR) United States $0.467B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.465B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.458B 0.00
Bioventus (BVS) United States $0.453B 17.33
Lexeo Therapeutics (LXEO) United States $0.447B 0.00
Harrow (HROW) United States $0.427B 0.00
Heron Therapeutics (HRTX) United States $0.424B 0.00
Esperion Therapeutics (ESPR) United States $0.423B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.406B 0.00
Korro Bio (KRRO) United States $0.403B 0.00
Organogenesis (ORGO) United States $0.392B 74.00
Tourmaline Bio (TRML) United States $0.370B 0.00
Black Diamond Therapeutics (BDTX) United States $0.334B 0.00
Nanobiotix S.A (NBTX) France $0.323B 0.00
Nektar Therapeutics (NKTR) United States $0.321B 0.00
Aquestive Therapeutics (AQST) United States $0.298B 0.00
Fractyl Health (GUTS) United States $0.292B 0.00
Nature's Sunshine Products (NATR) United States $0.291B 18.46
Xeris Biopharma Holdings (XERS) United States $0.280B 0.00
Adherex Technologies (FENC) United States $0.274B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.273B 0.00
Akebia Therapeutics (AKBA) United States $0.270B 0.00
ESSA Pharma (EPIX) Canada $0.262B 0.00
Pyxis Oncology (PYXS) United States $0.253B 0.00
Metagenomi (MGX) United States $0.245B 0.00
Foghorn Therapeutics (FHTX) United States $0.241B 0.00
Eliem Therapeutics (ELYM) United States $0.233B 0.00
Conduit Pharmaceuticals (CDT) United States $0.228B 0.00
Aldeyra Therapeutics (ALDX) United States $0.220B 0.00
Avita Medical (RCEL) United States $0.215B 0.00
Zevra Therapeutics (ZVRA) United States $0.205B 0.00
Telomir Pharmaceuticals (TELO) United States $0.197B 0.00
Century Therapeutics (IPSC) United States $0.194B 0.00
Acrivon Therapeutics (ACRV) United States $0.192B 0.00
Galectin Therapeutics (GALT) United States $0.191B 0.00
Profound Medical (PROF) Canada $0.187B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.172B 0.00
MediWound (MDWD) Israel $0.168B 0.00
Incannex Healthcare (IXHL) Australia $0.166B 0.00
Achieve Life Sciences (ACHV) Canada $0.165B 0.00
Prelude Therapeutics (PRLD) United States $0.160B 0.00
Cardiol Therapeutics (CRDL) Canada $0.149B 0.00
CytoDyn (CYDY) United States $0.146B 0.00
VAXART, INC (VXRT) United States $0.145B 0.00
Elite Pharmaceuticals (ELTP) United States $0.145B 13.56
Regulus Therapeutics (RGLS) United States $0.137B 0.00
OptiNose (OPTN) United States $0.132B 0.00
Karyopharm Therapeutics (KPTI) United States $0.132B 0.00
Context Therapeutics (CNTX) United States $0.126B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.124B 8.27
FibroGen (FGEN) United States $0.120B 0.00
Citius Pharmaceuticals (CTXR) United States $0.111B 0.00
PMV Pharmaceuticals (PMVP) United States $0.110B 0.00
Inotiv (NOTV) United States $0.108B 0.00
Relmada Therapeutics (RLMD) United States $0.107B 0.00
Vivani Medical (VANI) United States $0.102B 0.00
ProPhase Labs (PRPH) United States $0.101B 0.00
Assertio Holdings (ASRT) United States $0.100B 4.57
AlloVir (ALVR) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
Jaguar Animal Health (JAGX) United States $0.080B 0.00
SCYNEXIS (SCYX) United States $0.077B 1.09
Marinus Pharmaceuticals (MRNS) United States $0.074B 0.00
Tempest Therapeutics (TPST) United States $0.073B 0.00
Journey Medical (DERM) United States $0.071B 0.00
Protara Therapeutics (TARA) United States $0.067B 0.00
Champions Oncology (CSBR) United States $0.064B 0.00
Mural Oncology (MURA) Ireland $0.063B 0.00
Carisma Therapeutics (CARM) United States $0.061B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.053B 0.00
BioLineRx (BLRX) Israel $0.050B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.047B 0.00
Gain Therapeutics (GANX) United States $0.044B 0.00
ElectroCore (ECOR) United States $0.044B 0.00
VYNE Therapeutics (VYNE) United States $0.041B 0.00
Unicycive Therapeutics (UNCY) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
Nutriband (NTRB) United States $0.040B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.036B 0.00
JanOne (JAN) United States $0.034B 0.00
CASI Pharmaceuticals (CASI) China $0.034B 0.00
DURECT (DRRX) United States $0.033B 0.00
Surrozen (SRZN) United States $0.033B 0.00
NRx Pharmaceuticals (NRXP) United States $0.032B 0.00
Viracta Therapeutics (VIRX) United States $0.030B 0.00
Lipocine (LPCN) United States $0.028B 0.00
Aptorum Group (APM) United Kingdom $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Oncternal Therapeutics (ONCT) United States $0.025B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
PolyPid (PYPD) Israel $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 0.00
Lyra Therapeutics (LYRA) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.021B 0.80
Alaunos Therapeutics (TCRT) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Indaptus Therapeutics (INDP) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Talphera (TLPH) United States $0.018B 0.00
CERo Therapeutics Holdings (CERO) United States $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.016B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Avalo Therapeutics (AVTX) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Vivos Therapeutics (VVOS) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Clever Leaves Holdings (CLVR) Canada $0.004B 0.00
TransCode Therapeutics (RNAZ) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Avenue Therapeutics (ATXI) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.29
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 38.29